Promising rodent models in Parkinson's disease

Paola Imbriani, Giuseppe Sciamanna, Massimo Santoro, Tommaso Schirinzi, Antonio Pisani

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: In the past decade, the study of the pathogenic mechanisms underlying neurodegeneration in Parkinson's disease (PD) has revealed a genetic component, often associated with a number of environmental risk factors. Animal models have improved our understanding of disease pathogenesis, providing significant insights into the understanding of novel molecular pathways. Each model has its own specific features and limitations, and the choice of the most appropriate one depends on the specific question that has to be answered. Aim: To provide an overview of some of the models supporting the hypothesis that early synaptic dysfunction represents a central event in the course of the disease. Development: Along with "classical" models, based on the administration of neurotoxins and capable of replicating the neuropathological hallmarks of the disease, a number of genetic models, reproducing the disease-causing mutations of monogenic forms of familial PD, have been generated. More recently, novel models have been developed, based on the combination of a toxic insult together with PD mutations, allowing for the identification of dysfunction at a prodromal disease stage. Conclusions: The development and characterization of new models is crucial for a better understanding of PD related-synaptopathy, and hold promise for the identification of novel therapeutics.

Original languageEnglish
JournalParkinsonism and Related Disorders
DOIs
Publication statusE-pub ahead of print - Jul 2017

Fingerprint

Parkinson Disease
Rodentia
Prodromal Symptoms
Mutation
Poisons
Genetic Models
Neurotoxins
Animal Models
Therapeutics

Keywords

  • Animal models
  • Dopamine
  • Striatum
  • Synaptic plasticity

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

Promising rodent models in Parkinson's disease. / Imbriani, Paola; Sciamanna, Giuseppe; Santoro, Massimo; Schirinzi, Tommaso; Pisani, Antonio.

In: Parkinsonism and Related Disorders, 07.2017.

Research output: Contribution to journalArticle

@article{f2616f1f954f4a7c98a6ef3a458165d4,
title = "Promising rodent models in Parkinson's disease",
abstract = "Background: In the past decade, the study of the pathogenic mechanisms underlying neurodegeneration in Parkinson's disease (PD) has revealed a genetic component, often associated with a number of environmental risk factors. Animal models have improved our understanding of disease pathogenesis, providing significant insights into the understanding of novel molecular pathways. Each model has its own specific features and limitations, and the choice of the most appropriate one depends on the specific question that has to be answered. Aim: To provide an overview of some of the models supporting the hypothesis that early synaptic dysfunction represents a central event in the course of the disease. Development: Along with {"}classical{"} models, based on the administration of neurotoxins and capable of replicating the neuropathological hallmarks of the disease, a number of genetic models, reproducing the disease-causing mutations of monogenic forms of familial PD, have been generated. More recently, novel models have been developed, based on the combination of a toxic insult together with PD mutations, allowing for the identification of dysfunction at a prodromal disease stage. Conclusions: The development and characterization of new models is crucial for a better understanding of PD related-synaptopathy, and hold promise for the identification of novel therapeutics.",
keywords = "Animal models, Dopamine, Striatum, Synaptic plasticity",
author = "Paola Imbriani and Giuseppe Sciamanna and Massimo Santoro and Tommaso Schirinzi and Antonio Pisani",
year = "2017",
month = "7",
doi = "10.1016/j.parkreldis.2017.07.027",
language = "English",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Promising rodent models in Parkinson's disease

AU - Imbriani, Paola

AU - Sciamanna, Giuseppe

AU - Santoro, Massimo

AU - Schirinzi, Tommaso

AU - Pisani, Antonio

PY - 2017/7

Y1 - 2017/7

N2 - Background: In the past decade, the study of the pathogenic mechanisms underlying neurodegeneration in Parkinson's disease (PD) has revealed a genetic component, often associated with a number of environmental risk factors. Animal models have improved our understanding of disease pathogenesis, providing significant insights into the understanding of novel molecular pathways. Each model has its own specific features and limitations, and the choice of the most appropriate one depends on the specific question that has to be answered. Aim: To provide an overview of some of the models supporting the hypothesis that early synaptic dysfunction represents a central event in the course of the disease. Development: Along with "classical" models, based on the administration of neurotoxins and capable of replicating the neuropathological hallmarks of the disease, a number of genetic models, reproducing the disease-causing mutations of monogenic forms of familial PD, have been generated. More recently, novel models have been developed, based on the combination of a toxic insult together with PD mutations, allowing for the identification of dysfunction at a prodromal disease stage. Conclusions: The development and characterization of new models is crucial for a better understanding of PD related-synaptopathy, and hold promise for the identification of novel therapeutics.

AB - Background: In the past decade, the study of the pathogenic mechanisms underlying neurodegeneration in Parkinson's disease (PD) has revealed a genetic component, often associated with a number of environmental risk factors. Animal models have improved our understanding of disease pathogenesis, providing significant insights into the understanding of novel molecular pathways. Each model has its own specific features and limitations, and the choice of the most appropriate one depends on the specific question that has to be answered. Aim: To provide an overview of some of the models supporting the hypothesis that early synaptic dysfunction represents a central event in the course of the disease. Development: Along with "classical" models, based on the administration of neurotoxins and capable of replicating the neuropathological hallmarks of the disease, a number of genetic models, reproducing the disease-causing mutations of monogenic forms of familial PD, have been generated. More recently, novel models have been developed, based on the combination of a toxic insult together with PD mutations, allowing for the identification of dysfunction at a prodromal disease stage. Conclusions: The development and characterization of new models is crucial for a better understanding of PD related-synaptopathy, and hold promise for the identification of novel therapeutics.

KW - Animal models

KW - Dopamine

KW - Striatum

KW - Synaptic plasticity

UR - http://www.scopus.com/inward/record.url?scp=85026451600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026451600&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2017.07.027

DO - 10.1016/j.parkreldis.2017.07.027

M3 - Article

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

ER -